ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
6.43
-0.39 (-5.72%)
At close: Mar 28, 2025, 4:00 PM
6.31
-0.12 (-1.83%)
Pre-market: Mar 31, 2025, 5:08 AM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 61 employees as of December 31, 2023. The number of employees increased by 37 or 154.17% compared to the previous year.
Employees
61
Change (1Y)
37
Growth (1Y)
154.17%
Revenue / Employee
$183,164
Profits / Employee
-$2,991,213
Market Cap
413.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABVX News
- 4 days ago - Abivax publishes financial reports with the French and U.S. securities regulatory agencies - GlobeNewsWire
- 7 days ago - Abivax Announces Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 - GlobeNewsWire
- 2 months ago - Abivax Publishes 2025 Financial Calendar - GlobeNewsWire
- 2 months ago - Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress - GlobeNewsWire
- 2 months ago - Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment - GlobeNewsWire
- 3 months ago - Abivax Announces a Change to the Composition of its Board of Directors - GlobeNewsWire
- 4 months ago - Abivax Establishes an At-the-Market (ATM) Program on Nasdaq - GlobeNewsWire